Executive-Led Medical Trade Mission to India Mumbai, New Delhi and Hyderabad March 2-8, 2012, 70113-70116 [2011-28590]
Download as PDF
jlentini on DSK4TPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices
evidence in its ministerial error
allegation that it was the Department’s
intention in preparing the final results
to use either the labor rate methodology
announced on June 21, 2011, or to value
lime using any surrogate value other
than the one it used in the final results.
Thus, XITIC’s allegations do not fall
under the definition of a ministerial
error set forth in 751(h) of the Act and
19 CFR 351.224(f). Therefore, the
Department has not amended the final
results with respect to XITIC’s
allegations.
Finally, Iceman Group argues that the
Department made a clerical error by
including Iceman Group in the
proceedings. Iceman Group claims that
no party requested a review of Iceman
Group, and that the Department did not
initiate an administrative review of
shipments by Iceman Group. Instead,
Iceman Group argues, petitioners
requested a review of Zhejiang Iceman
Food, Co., Ltd. (‘‘Iceman Food’’), and it
was on this entity that the Department
initiated an administrative review.
Petitioner argues the Department
should reject Iceman Group’s argument
for three reasons: (1) Iceman Group
actively participated in the
administrative proceedings before the
Department (submitting a separate rate
certification) and its counsel filed an
entry of appearance on behalf of Iceman
Food; (2) the Department’s Preliminary
Results 2 specifically identified Iceman
Group as an entity preliminarily eligible
for a separate rate; and (3) Iceman
Group’s attempt to raise this issue as a
clerical error—rather than having raised
it during the Department’s on-going
proceedings—is an inappropriate use of
the clerical error provision in the
Department’s regulations.
After analyzing the interested parties’
allegations and reply comments
regarding Iceman Group, in accordance
with section 751(h) of the Act and 19
CFR 351.224(e), we find that the
Department did not err by including
Iceman Group in the proceedings. First,
the allegations made by Iceman Group
do not fall under the definition of
‘‘ministerial error’’ set forth in 751(h) of
the Act and 19 CFR 351.224(f).
Additionally, four reasons support
equating Iceman Group with the entity
Iceman Food: (1) Counsel filed an entry
of appearance on behalf of Iceman Food
on April 5, 2010; (2) Iceman Group,
which never filed a separate notice of
appearance, filed a certification for a
separate rate on April 29, 2010; (3) the
2 See Certain Preserved Mushrooms From the
People’s Republic of China: Preliminary Results of
Antidumping Duty Administrative Review,
Recission in Part, and Intent to Rescind in Part, 76
FR 12704 (March 8, 2011) (Preliminary Results)
VerDate Mar<15>2010
16:38 Nov 09, 2011
Jkt 226001
separate rate certification filed by
Iceman Group lists the company Web
site as www.icemanfood.com and the
company email address as
‘‘jacky@icemanfood.com;’’ and (4)
Iceman Group did not comment on the
Preliminary Results, which specifically
list Iceman Group as preliminarily
receiving a separate rate. Therefore, the
Department correctly and reasonably
assigned a separate rate to Iceman
Group as a result of counsel’s
representation of Iceman Group and
Iceman Food, and the party’s own
actions before the Department
indicating that the two names apply to
the same company which is subject to
the review. Thus, the Department will
not amend the Final Results for Iceman
Group other than to account for
adjustments to the weighted-average
margin for companies that applied for
separate-rates status as described above.
Amended Final Results of the Review
The Department has determined that
the following amended margins exist for
the period February 1, 2009, through
January 31, 2010.
Weightedaverage
margin
(percent)
Exporter
Blue Field (Sichuan) Food
Industrial Co., Ltd ..............
Ayecue (Liaocheng) Foodstuff Co., Ltd .....................
Fujian Golden Banyan Foodstuffs Industrial Co., Ltd ....
Shandong Jiufa Edible Fungus Corporation, Ltd .........
Zheijiang Iceman Group Co.,
Ltd .....................................
2.17
76.12
Fmt 4703
Sfmt 4703
Dated: November 4, 2011.
Paul Piquado,
Assistant Secretary for Import
Administration.
[FR Doc. 2011–29175 Filed 11–9–11; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
Executive-Led Medical Trade Mission
to India Mumbai, New Delhi and
Hyderabad March 2–8, 2012
76.12
76.12
Mission Description
Cash Deposit Requirements
Cash deposit requirements related to
the amended final results will be
effective retroactively for all shipments
of the subject merchandise entered, or
withdrawn from warehouse, for
consumption on or after the publication
date of the final results, as provided by
section 751(a)(2)(C) of the Act. The cash
deposit rates for companies whose rate
was corrected are noted above. For
Frm 00007
previously investigated or reviewed PRC
and non-PRC exporters that have
separate rates whose rate has not
changed as a result of these amended
final results, the cash deposit rate will
continue to be the exporter-specific rate
published for the most recent period.
For all PRC exporters of subject
merchandise which have not been
found to be entitled to a separate rate,
the cash deposit rate will be the PRCwide rate of 198.63 percent. For all nonPRC exporters of subject merchandise
which have not received their own rate,
the cash deposit will be the rate
applicable to the PRC exporters that
supplied that non-PRC exporter. These
deposit requirements shall remain in
effect until further notice.
These amended final results are
published in accordance with sections
751(h) and 777(i)(1) of the Act.
International Trade
Administration, Commerce.
ACTION: Notice.
76.12
Assessment Rates
Pursuant to section 751(a)(2)(A) of the
Act and 19 CFR 351.212(b), the
Department shall determine, and U.S.
Customs and Border Protection (CBP)
shall assess, antidumping duties on all
appropriate entries. The Department
intends to issue assessment instructions
to CBP that are related to the amended
final results 15 days after the of
publication of the amended final results
of review.
PO 00000
70113
AGENCY:
The United States Department of
Commerce, International Trade
Administration, U.S. and Foreign
Commercial Service (CS) is organizing
an Executive-Led Medical Trade
Mission to India from March 2–8, 2012.
The Medical Trade Mission to India is
intended to include representatives
from a variety of U.S. medical/
healthcare industry manufacturers
(equipment/devices, laboratory
equipments, emergency equipment,
diagnostic, physiotherapy and
orthopedic, healthcare information
technology, and other allied sectors),
service providers, and associations and
trade organizations. The mission will
introduce the participants to the
government bodies, end-users and
prospective partners whose needs and
capabilities are best suited to each U.S.
participant’s strengths. Participating in
an official U.S. industry delegation,
rather than traveling to India on their
own, will enhance the participants’
E:\FR\FM\10NON1.SGM
10NON1
70114
Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices
jlentini on DSK4TPTVN1PROD with NOTICES
ability to secure meetings in India. The
delegates will meet with government
officials to obtain first-hand information
about the regulations, policies and
procedures in the healthcare industry. It
will be an opportunity for participants
to visit healthcare facilities to get
acquainted with the functioning of
hospitals in India and the varied
standards. Market forces, such as
medical tourism, insurance and
corporate sector have accelerated the
demand for quality in healthcare
services. As a result, there is a growing
demand from consumers for better
healthcare as the lack of quality
assurance mechanisms limits their
access to appropriate health services.
The Healthcare industry is now
proactively creating standards for the
medical tourism industry with the help
of credit rating agencies, insurance
companies and others involved in the
self regulation of the sector. The
National Accreditation Board for
Hospitals (NABH) has been set-up to
establish and operate accreditation
programs for healthcare organizations.
Some private hospitals are also applying
for accreditation from bodies such as the
Joint Commission International (JCI).
The mission will include appointments
and briefings in Mumbai, New Delhi
and Hyderabad, India’s major healthcare
industry hubs. Trade mission
participants will have the opportunity
to interact extensively with Embassy/
Consulate Officials and Commercial
Service (CS) India healthcare specialists,
to discuss industry developments,
opportunities, and sales strategies.
There is an option in the mission to
participate in Medical Fair India. The
Medical Fair India is the 18th
International Exhibition and Conference
on Diagnostic, Medical Technology,
Rehabilitation, Medical Equipment and
Components. MEDICAL FAIR INDIA
offers a new platform for technology and
service solutions for use in the medical
engineering industry—from new
materials, components, intermediate
products, packaging and services all the
way over to more complex micro system
technology and nanotechnology. For
more information on Medical Fair India,
please visit https://www.medicalfairindia.com/. For the last three years the
U.S. Department of Commerce has
certified the Medical Fair India.
Commercial Setting
The Indian healthcare industry is
experiencing a rapid transformation and
emerging to be a promising market for
U.S. suppliers of high end products
seeking partnership opportunities. The
Indian healthcare industry is estimated
at $50 billion industry in India and is
VerDate Mar<15>2010
16:38 Nov 09, 2011
Jkt 226001
expected to reach over $75 billion by
2012. There is a growing demand for
quality healthcare service. The Indian
population of 1 billion people is
growing at a rate of 1.6 percent per year.
The growth in affluence in India, which
now has over 400 million middleincome consumers, is creating demand
for a higher standard of healthcare. The
type of healthcare serviced required
have changed due to the change in the
demographic profile of India and the
rise of lifestyle-related diseases such as
diabetes, cardiovascular diseases, and
diseases of the central nervous system.
The number of individuals covered by
health plans is estimated at 20 million
presently, leaving a large portion of the
Indian population uninsured. The
potential market for healthcare services,
including healthcare information and
management systems, is expected to
grow at a faster pace as hospitals strive
to improve operational efficiencies in
managing patient records and other key
systems.
Currently, the medical infrastructure
in India is far from adequate with
demand for hospitals and beds far
surpassing availability. The problem is
most acute in rural India, which
accounts for over half of India’s
population; about 80 percent of
available hospital beds are located in
the urban centers, leaving only 20
percent for the larger rural population.
Both the Indian government and the
private sector are striving to bring about
rapid growth in the industry to manage
the increased demand for high quality
service. Construction of several new
hospitals as well as upgrades of existing
hospitals is planned. Healthcare is
provided through primary care facilities,
secondary and tertiary care hospitals.
While the first two categories are fully
managed by the government, tertiary
care hospitals are owned and managed
either by government or private sector.
The growth in medical infrastructure
is accompanied by increased demand
for medical equipment/devices. The
medical equipment segment is growing
at an impressive rate of 15 percent. The
demand for the medical equipment is
expected to reach $5 billion by 2012,
reflecting significant growth from the
current figure of $2.7 billion. The new
specialty and super-specialty hospital
facilities depend on the import of highend medical equipment, which accounts
for over 65 percent of the entire
healthcare market. The demand is
primarily for high-tech devices. Most
Indian healthcare institutes use foreign
medical equipment for the purpose of
diagnosis, treatment and surgery. The
government has identified healthcare as
a priority sector and has taken the
PO 00000
Frm 00008
Fmt 4703
Sfmt 4703
following measures to promote this
industry:
• 100 per cent foreign direct
investment (FDI) is permitted for health
and medical services under the
automatic route. (FDI in sectors/
activities to the extent permitted under
automatic route does not require any
prior approval either by the Government
or Reserve Bank of India (RBI). The
investors are only required to notify the
Regional Office concerned of RBI within
30 days of receipt of inward remittances
and file the required documents with
that office within 30 days of issue of
shares of foreign investors.
• The National Rural Health Mission
(NRHM) has allocated US$ 10.15 billion
for the up-grading and capacity
enhancement of healthcare facilities.
• Moreover, in order to meet the
revised cost of construction, in March
2010 the Government of India (GOI)
allocated an additional US$ 1.2 billion
for the construction of six All India
Institute of Medical Sciences (AIIMS)like institutes and up- grade of 13
existing Government Medical Colleges.
Medical tourism is one of the major
external drivers of growth of the Indian
healthcare sector. The cost of major
surgeries in India remains relatively
low. Government and private sector
estimates the value of this segment of
the industry will reach $1.5 billion by
2012. The healthcare industry is now
proactively creating standards for the
medical tourism industry with the help
of credit rating agencies, insurance
companies and others involved in the
self regulation of the sector. The
National Accreditation Board for
Hospitals (NABH) has been set-up to
establish and operate accreditation
programs for healthcare organizations.
Some private hospitals are also applying
for accreditation from bodies such as the
Joint Commission International (JCI).
The growth in this industry makes it
very attractive for U.S. companies, both
large companies already doing business
in the market but also and especially
small- and medium- sized enterprises
(SMEs), and new-to-market (NTM)
companies.
Mission Goals
The goal of the Medical Trade
Mission to India is to (1) familiarize the
participants with the current healthcare
situation as well as the developments
taking place in India (2) introduce
participants to government officials in
India to learn about various regulatory
procedures and policies in the
healthcare sector (3) introduce
participants to Indian companies for
potential partnerships.
E:\FR\FM\10NON1.SGM
10NON1
Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices
Mission Scenario
The first stop on the mission itinerary
is Mumbai, the financial capital of
India, located in western India. New
Delhi and Hyderabad are the second and
third stops of the mission and are
located in northern and western India.
Several corporate hospital chains have
their headquarters in these cities. These
include Max group and Medicity
Medanta in New Delhi, the Apollo
group in Hyderabad, Fortis and the Tata
Research in Mumbai.
In all three cities the delegates will
attend Embassy and industry briefings,
networking events and take part in
business matchmaking appointments
with private-sector organizations. As
New Delhi is the capital city and home
to Central (Federal) Government, the
participants will have an opportunity in
New Delhi to meet the representatives of
the Ministry of Health, Drugs Controller
Generals Office, and Department of
Pharmaceutical. The U.S. mission
Friday, March 2 ...................................................
Saturday, March 3 ...............................................
Sunday, March 4 .................................................
Monday, March 5 ................................................
Tuesday, March 6 ...............................................
Wednesday, March 7 ..........................................
jlentini on DSK4TPTVN1PROD with NOTICES
Thursday, March 8 ..............................................
VerDate Mar<15>2010
16:38 Nov 09, 2011
Jkt 226001
members will learn about policies,
procedures and opportunities in the
country’s healthcare industry.
These three cities are each regional
hubs for the medical/healthcare
industry. The end-users of the
healthcare industry often prefer to be
serviced by regional distributors/agents
rather than country-wide distributors.
Thus, medical equipment importers/
distributors are based in these cities to
supply and service the regions
surrounding each of the cities. The three
cities will serve as good locations for
business one-on-one matchmaking
meetings and networking.
U.S. participants will be counseled
before and after the mission by U.S.
Export Assistance Center trade
specialists, primarily by members of the
Global Healthcare Team. Participation
in the mission will include the
following:
• Pre-travel briefings/Webinar on
subjects ranging from business practices
in India to security;
70115
• Embassy/Consulate briefings on the
business climate, political scenario,
medical/healthcare industry scenario;
• Industry briefings ‘‘Doing business
in India—focus sector medical/
healthcare’’;
• Pre-scheduled meetings with
potential partners, distributors, end
users, or local industry contacts in
Mumbai, New Delhi and Hyderabad;
• Meetings with Indian Government
officials in New Delhi;
• Tour of hospitals and interaction
with senior hospital staff and
procurement head (all the three stops);
and
• Networking receptions in three
cities of the trade mission.
Proposed Timetable
Mission participants will be
encouraged to arrive Thursday, March 1,
2012 to allow time to adjust to their new
surroundings before the mission
program begins on Friday, March 2.
Mumbai.
Morning: Consulate & Industry briefing by U.S. Department of Commerce at the hotel.
Noon/Afternoon:
Option I—Trade Mission.
One-on-One business matchmaking appointments at the hotel.
Lunch—private lunch.
Option II—participate/exhibit in Medical Fair 2012 by Messe Dusseldorf.
Evening: Networking reception at the hotel.
Mumbai/New Delhi.
Option I—
Morning: One-on-One business matchmaking appointments at the hotel.
Late afternoon: Check-out of the hotel & depart for Mumbai airport.
Travel to New Delhi.
Evening: Arrive New Delhi.
Option II—participate/exhibit in Medical Fair 2012 by Messe Dusseldorf. Delegates in Option 2
depart for New Delhi on Sunday, March 4, 2011.
New Delhi.
Free day for the delegates in Option 1/Travel Day for the Delegates in Option II.
New Delhi.
Morning: Breakfast briefing by the U.S. Commercial Service at hotel.
Meetings with the Government of India Ministries.
Lunch: Private lunch.
Afternoon: One-on-one matchmaking meeting at the hotel
Evening: Networking reception.
New Delhi/Hyderabad.
Morning: One-on-one matchmaking meeting at the hotel.
Lunch on own.
Late afternoon: Check-out of the hotel & depart for New Delhi airport.
Travel to Hyderabad.
Evening: Arrive Hyderabad.
Hyderabad.
Morning: One-on-One business matchmaking appointments at the hotel.
Private lunch.
Afternoon: One-on-One business matchmaking appointments at the hotel.
Evening: Networking reception.
Hyderabad.
Hospital chain visit and meeting with senior management.
Lunch on own.
Evening: Check-out of the hotel.
Depart for Hyderabad International airport for onward travel.
PO 00000
Frm 00009
Fmt 4703
Sfmt 4703
E:\FR\FM\10NON1.SGM
10NON1
70116
Federal Register / Vol. 76, No. 218 / Thursday, November 10, 2011 / Notices
Participation Requirements
All parties interested in participating
in the India Medical Trade Mission
must complete and submit an
application for consideration by the
Department of Commerce. All
applicants will be evaluated on their
ability to meet certain conditions and
best satisfy the selection criteria as
outlined below. A minimum of 15 and
a maximum of 20 companies will be
selected to participate in the mission
from the applicant pool. U.S. companies
already doing business in India as well
as U.S. companies seeking to enter the
Indian market for the first may apply.
Fees and Expenses
After a company or organization has
been selected to participate on the
mission, a payment to the Department of
Commerce in the form of a participation
fee is required.
Option 1: The participation fee for the
three city (Mumbai, New Delhi and
Hyderabad) Trade Mission will be
$4537.00 for a small or medium-sized
enterprise (SME),* or trade organization,
and $5225.00 for large firms. The fee for
each additional firm representative
(large firm or SME/trade organization) is
$500.
Option 2: Fee, for participants joining
the Trade Mission in two-cities (Delhi
and Hyderabad) will be $3,275.00 for
SMEs or trade organizations, and
$3950.00 for large companies. The fee
for each additional firm representative
(large firm or SME/trade organization) is
$500. Selecting option II * in Mumbai
i.e. exhibiting in Medical Fair India *
will be approximately $3547.00 for 9
sq.m. shell scheme space + $578.00 as
registration fees (this will be billed in
Euros).
(* Fee for participating in the Medical
Fair 2012 is separate and will have to be
paid directly to the organizers Messe
Dusseldorf.)
Expenses for lodging, some meals,
incidentals, and travel (except for
transportation to and from meetings)
will be the responsibility of each
mission participant.
application and supplemental
application materials, including
adequate information on the company’s
products and/or services (or in the case
of a trade association or trade
organization, information on the
products and/or services of the
companies to be represented on the
trade mission), primary market
objectives, and goals for participation. If
the Department of Commerce receives
an incomplete application, the
Department may reject the application,
request additional information, or take
the lack of information into account
when evaluating the applications.
• Each applicant must also certify
that the products and services it seeks
to export through the mission are either
produced in the United States, or, if not,
marketed under the name of a U.S. firm
and have at least fifty-one percent U.S.
content. In the case of a trade
association or trade organization, the
applicant must certify that, for each
company to be represented by the trade
association or trade organization, the
products and services the represented
company seeks to export are either
produced in the United States, or, if not,
marketed under the name of a U.S. firm
and have at least fifty-one percent U.S.
content.
jlentini on DSK4TPTVN1PROD with NOTICES
Conditions for Participation
• An applicant must submit a
completed and signed mission
Selection Criteria for Participation
Selection will be based on the
following criteria:
• Suitability of a company’s (or, the
case of a trade association or trade
organization, representing companies’)
products or services to the mission’s
goals.
• Company’s (or, in the case of a trade
association or trade organization,
represented companies’) potential for
business in India, including likelihood
of exports resulting from the trade
mission.
• Consistency of the applicant’s goals
and objectives with the stated scope of
the trade mission.
Referrals from political organizations
and any documents containing
references to partisan political activities
(including political contributions) will
be removed from an applicant’s
submission and not considered during
the selection process.
* An SME is defined as a firm with 500 or fewer
employees or that otherwise qualifies as a small
business under SBA regulations (see https://
www.sba.gov/category/navigation-structure/
contracting/contracting-officials/size-standards).
Parent companies, affiliates, and subsidiaries will
be considered when determining business size. The
dual pricing schedule reflects the Commercial
Service’s user fee schedule that became effective
May 1, 2008 (for additional information see
https://www.export.gov/newsletter/march2008/
initiatives.html).
Timeframe for Recruitment and
Applications
Mission recruitment will be
conducted in an open and public
manner, including publication in the
Federal Register (https://
www.gpoaccess.gov/fr), posting on ITA’s
trade mission calendar—www.trade.gov/
trade-missions—and other Internet Web
sites, press releases to general and trade
VerDate Mar<15>2010
16:38 Nov 09, 2011
Jkt 226001
PO 00000
Frm 00010
Fmt 4703
Sfmt 4703
media, direct mail, broadcast fax,
notices by industry trade associations
and other multiplier groups, and
publicity at industry meetings,
symposia, conferences, and trade shows.
Recruitment for the mission will
begin immediately and conclude no
later than December 22, 2011. The U.S.
Department of Commerce will review
applications and make selection
decisions on a rolling basis. We will
inform all applicants of selection
decisions as soon as possible after the
applications are reviewed. Applications
received after the December 22 deadline
will be considered only if space and
scheduling constraints permit.
Contacts
U.S. Commercial Service
Ms. September Secrist, Healthcare
Team: International Trade Specialist,
U.S. Commercial Service, U.S.
Department of Commerce, 2001 6th
Avenue, Suite 2610, Seattle, WA
98121, Phone: (206) 553–5615x229,
Fax: (206) 553–7253.
U.S. Commercial Service in India
Ms. Ruma Chatterjee, U.S. Commercial
Service Mumbai, Ph: 91–22–2265
2511, Fax: 91–22–22652850,
Ruma.Chatterjee@trade.gov.
Mr. Sandeep Maini, U.S. Commercial
Service New Delhi, Ph: 91–11–
23472222, Fax: 91–11–2331 5172,
Sandeep.Maini@trade.gov.
Elnora Moye,
Trade Program Assistant.
[FR Doc. 2011–28590 Filed 11–9–11; 8:45 am]
BILLING CODE 3510–FP–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration (NOAA)
National Climate Assessment and
Development Advisory Committee
(NCADAC)
Office of Oceanic and
Atmospheric Research (OAR), National
Oceanic and Atmospheric
Administration (NOAA), Department of
Commerce (DOC).
ACTION: Notice of time changes for
public meeting and public comment
period.
AGENCY:
The National Climate
Assessment and Development Advisory
Committee (NCADAC) was established
by the Secretary of Commerce under the
authority of the Global Change Research
Act of 1990 to synthesize and
summarize the science and information
SUMMARY:
E:\FR\FM\10NON1.SGM
10NON1
Agencies
[Federal Register Volume 76, Number 218 (Thursday, November 10, 2011)]
[Notices]
[Pages 70113-70116]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-28590]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
International Trade Administration
Executive-Led Medical Trade Mission to India Mumbai, New Delhi
and Hyderabad March 2-8, 2012
AGENCY: International Trade Administration, Commerce.
ACTION: Notice.
-----------------------------------------------------------------------
Mission Description
The United States Department of Commerce, International Trade
Administration, U.S. and Foreign Commercial Service (CS) is organizing
an Executive-Led Medical Trade Mission to India from March 2-8, 2012.
The Medical Trade Mission to India is intended to include
representatives from a variety of U.S. medical/healthcare industry
manufacturers (equipment/devices, laboratory equipments, emergency
equipment, diagnostic, physiotherapy and orthopedic, healthcare
information technology, and other allied sectors), service providers,
and associations and trade organizations. The mission will introduce
the participants to the government bodies, end-users and prospective
partners whose needs and capabilities are best suited to each U.S.
participant's strengths. Participating in an official U.S. industry
delegation, rather than traveling to India on their own, will enhance
the participants'
[[Page 70114]]
ability to secure meetings in India. The delegates will meet with
government officials to obtain first-hand information about the
regulations, policies and procedures in the healthcare industry. It
will be an opportunity for participants to visit healthcare facilities
to get acquainted with the functioning of hospitals in India and the
varied standards. Market forces, such as medical tourism, insurance and
corporate sector have accelerated the demand for quality in healthcare
services. As a result, there is a growing demand from consumers for
better healthcare as the lack of quality assurance mechanisms limits
their access to appropriate health services. The Healthcare industry is
now proactively creating standards for the medical tourism industry
with the help of credit rating agencies, insurance companies and others
involved in the self regulation of the sector. The National
Accreditation Board for Hospitals (NABH) has been set-up to establish
and operate accreditation programs for healthcare organizations. Some
private hospitals are also applying for accreditation from bodies such
as the Joint Commission International (JCI). The mission will include
appointments and briefings in Mumbai, New Delhi and Hyderabad, India's
major healthcare industry hubs. Trade mission participants will have
the opportunity to interact extensively with Embassy/Consulate
Officials and Commercial Service (CS) India healthcare specialists, to
discuss industry developments, opportunities, and sales strategies.
There is an option in the mission to participate in Medical Fair
India. The Medical Fair India is the 18th International Exhibition and
Conference on Diagnostic, Medical Technology, Rehabilitation, Medical
Equipment and Components. MEDICAL FAIR INDIA offers a new platform for
technology and service solutions for use in the medical engineering
industry--from new materials, components, intermediate products,
packaging and services all the way over to more complex micro system
technology and nanotechnology. For more information on Medical Fair
India, please visit https://www.medicalfair-india.com/. For the last
three years the U.S. Department of Commerce has certified the Medical
Fair India.
Commercial Setting
The Indian healthcare industry is experiencing a rapid
transformation and emerging to be a promising market for U.S. suppliers
of high end products seeking partnership opportunities. The Indian
healthcare industry is estimated at $50 billion industry in India and
is expected to reach over $75 billion by 2012. There is a growing
demand for quality healthcare service. The Indian population of 1
billion people is growing at a rate of 1.6 percent per year. The growth
in affluence in India, which now has over 400 million middle-income
consumers, is creating demand for a higher standard of healthcare. The
type of healthcare serviced required have changed due to the change in
the demographic profile of India and the rise of lifestyle-related
diseases such as diabetes, cardiovascular diseases, and diseases of the
central nervous system. The number of individuals covered by health
plans is estimated at 20 million presently, leaving a large portion of
the Indian population uninsured. The potential market for healthcare
services, including healthcare information and management systems, is
expected to grow at a faster pace as hospitals strive to improve
operational efficiencies in managing patient records and other key
systems.
Currently, the medical infrastructure in India is far from adequate
with demand for hospitals and beds far surpassing availability. The
problem is most acute in rural India, which accounts for over half of
India's population; about 80 percent of available hospital beds are
located in the urban centers, leaving only 20 percent for the larger
rural population. Both the Indian government and the private sector are
striving to bring about rapid growth in the industry to manage the
increased demand for high quality service. Construction of several new
hospitals as well as upgrades of existing hospitals is planned.
Healthcare is provided through primary care facilities, secondary and
tertiary care hospitals. While the first two categories are fully
managed by the government, tertiary care hospitals are owned and
managed either by government or private sector.
The growth in medical infrastructure is accompanied by increased
demand for medical equipment/devices. The medical equipment segment is
growing at an impressive rate of 15 percent. The demand for the medical
equipment is expected to reach $5 billion by 2012, reflecting
significant growth from the current figure of $2.7 billion. The new
specialty and super-specialty hospital facilities depend on the import
of high-end medical equipment, which accounts for over 65 percent of
the entire healthcare market. The demand is primarily for high-tech
devices. Most Indian healthcare institutes use foreign medical
equipment for the purpose of diagnosis, treatment and surgery. The
government has identified healthcare as a priority sector and has taken
the following measures to promote this industry:
100 per cent foreign direct investment (FDI) is permitted
for health and medical services under the automatic route. (FDI in
sectors/activities to the extent permitted under automatic route does
not require any prior approval either by the Government or Reserve Bank
of India (RBI). The investors are only required to notify the Regional
Office concerned of RBI within 30 days of receipt of inward remittances
and file the required documents with that office within 30 days of
issue of shares of foreign investors.
The National Rural Health Mission (NRHM) has allocated US$
10.15 billion for the up-grading and capacity enhancement of healthcare
facilities.
Moreover, in order to meet the revised cost of
construction, in March 2010 the Government of India (GOI) allocated an
additional US$ 1.2 billion for the construction of six All India
Institute of Medical Sciences (AIIMS)-like institutes and up- grade of
13 existing Government Medical Colleges.
Medical tourism is one of the major external drivers of growth of
the Indian healthcare sector. The cost of major surgeries in India
remains relatively low. Government and private sector estimates the
value of this segment of the industry will reach $1.5 billion by 2012.
The healthcare industry is now proactively creating standards for the
medical tourism industry with the help of credit rating agencies,
insurance companies and others involved in the self regulation of the
sector. The National Accreditation Board for Hospitals (NABH) has been
set-up to establish and operate accreditation programs for healthcare
organizations. Some private hospitals are also applying for
accreditation from bodies such as the Joint Commission International
(JCI).
The growth in this industry makes it very attractive for U.S.
companies, both large companies already doing business in the market
but also and especially small- and medium- sized enterprises (SMEs),
and new-to-market (NTM) companies.
Mission Goals
The goal of the Medical Trade Mission to India is to (1)
familiarize the participants with the current healthcare situation as
well as the developments taking place in India (2) introduce
participants to government officials in India to learn about various
regulatory procedures and policies in the healthcare sector (3)
introduce participants to Indian companies for potential partnerships.
[[Page 70115]]
Mission Scenario
The first stop on the mission itinerary is Mumbai, the financial
capital of India, located in western India. New Delhi and Hyderabad are
the second and third stops of the mission and are located in northern
and western India. Several corporate hospital chains have their
headquarters in these cities. These include Max group and Medicity
Medanta in New Delhi, the Apollo group in Hyderabad, Fortis and the
Tata Research in Mumbai.
In all three cities the delegates will attend Embassy and industry
briefings, networking events and take part in business matchmaking
appointments with private-sector organizations. As New Delhi is the
capital city and home to Central (Federal) Government, the participants
will have an opportunity in New Delhi to meet the representatives of
the Ministry of Health, Drugs Controller Generals Office, and
Department of Pharmaceutical. The U.S. mission members will learn about
policies, procedures and opportunities in the country's healthcare
industry.
These three cities are each regional hubs for the medical/
healthcare industry. The end-users of the healthcare industry often
prefer to be serviced by regional distributors/agents rather than
country-wide distributors. Thus, medical equipment importers/
distributors are based in these cities to supply and service the
regions surrounding each of the cities. The three cities will serve as
good locations for business one-on-one matchmaking meetings and
networking.
U.S. participants will be counseled before and after the mission by
U.S. Export Assistance Center trade specialists, primarily by members
of the Global Healthcare Team. Participation in the mission will
include the following:
Pre-travel briefings/Webinar on subjects ranging from
business practices in India to security;
Embassy/Consulate briefings on the business climate,
political scenario, medical/healthcare industry scenario;
Industry briefings ``Doing business in India--focus sector
medical/healthcare'';
Pre-scheduled meetings with potential partners,
distributors, end users, or local industry contacts in Mumbai, New
Delhi and Hyderabad;
Meetings with Indian Government officials in New Delhi;
Tour of hospitals and interaction with senior hospital
staff and procurement head (all the three stops); and
Networking receptions in three cities of the trade
mission.
Proposed Timetable
Mission participants will be encouraged to arrive Thursday, March
1, 2012 to allow time to adjust to their new surroundings before the
mission program begins on Friday, March 2.
------------------------------------------------------------------------
------------------------------------------------------------------------
Friday, March 2................... Mumbai.
Morning: Consulate & Industry
briefing by U.S. Department of
Commerce at the hotel.
Noon/Afternoon:
Option I--Trade Mission.
One-on-One business matchmaking
appointments at the hotel.
Lunch--private lunch.
Option II--participate/exhibit in
Medical Fair 2012 by Messe
Dusseldorf.
Evening: Networking reception at the
hotel.
Saturday, March 3................. Mumbai/New Delhi.
Option I--
Morning: One-on-One business
matchmaking appointments at the
hotel.
Late afternoon: Check-out of the
hotel & depart for Mumbai airport.
Travel to New Delhi.
Evening: Arrive New Delhi.
Option II--participate/exhibit in
Medical Fair 2012 by Messe
Dusseldorf. Delegates in Option 2
depart for New Delhi on Sunday,
March 4, 2011.
Sunday, March 4................... New Delhi.
Free day for the delegates in Option
1/Travel Day for the Delegates in
Option II.
Monday, March 5................... New Delhi.
Morning: Breakfast briefing by the
U.S. Commercial Service at hotel.
Meetings with the Government of
India Ministries.
Lunch: Private lunch.
Afternoon: One-on-one matchmaking
meeting at the hotel
Evening: Networking reception.
Tuesday, March 6.................. New Delhi/Hyderabad.
Morning: One-on-one matchmaking
meeting at the hotel.
Lunch on own.
Late afternoon: Check-out of the
hotel & depart for New Delhi
airport.
Travel to Hyderabad.
Evening: Arrive Hyderabad.
Wednesday, March 7................ Hyderabad.
Morning: One-on-One business
matchmaking appointments at the
hotel.
Private lunch.
Afternoon: One-on-One business
matchmaking appointments at the
hotel.
Evening: Networking reception.
Thursday, March 8................. Hyderabad.
Hospital chain visit and meeting
with senior management.
Lunch on own.
Evening: Check-out of the hotel.
Depart for Hyderabad International
airport for onward travel.
------------------------------------------------------------------------
[[Page 70116]]
Participation Requirements
All parties interested in participating in the India Medical Trade
Mission must complete and submit an application for consideration by
the Department of Commerce. All applicants will be evaluated on their
ability to meet certain conditions and best satisfy the selection
criteria as outlined below. A minimum of 15 and a maximum of 20
companies will be selected to participate in the mission from the
applicant pool. U.S. companies already doing business in India as well
as U.S. companies seeking to enter the Indian market for the first may
apply.
Fees and Expenses
After a company or organization has been selected to participate on
the mission, a payment to the Department of Commerce in the form of a
participation fee is required.
Option 1: The participation fee for the three city (Mumbai, New
Delhi and Hyderabad) Trade Mission will be $4537.00 for a small or
medium-sized enterprise (SME),* or trade organization, and $5225.00 for
large firms. The fee for each additional firm representative (large
firm or SME/trade organization) is $500.
Option 2: Fee, for participants joining the Trade Mission in two-
cities (Delhi and Hyderabad) will be $3,275.00 for SMEs or trade
organizations, and $3950.00 for large companies. The fee for each
additional firm representative (large firm or SME/trade organization)
is $500. Selecting option II * in Mumbai i.e. exhibiting in Medical
Fair India * will be approximately $3547.00 for 9 sq.m. shell scheme
space + $578.00 as registration fees (this will be billed in Euros).
(* Fee for participating in the Medical Fair 2012 is separate and
will have to be paid directly to the organizers Messe Dusseldorf.)
---------------------------------------------------------------------------
* An SME is defined as a firm with 500 or fewer employees or
that otherwise qualifies as a small business under SBA regulations
(see https://www.sba.gov/category/navigation-structure/contracting/contracting-officials/size-standards). Parent companies, affiliates,
and subsidiaries will be considered when determining business size.
The dual pricing schedule reflects the Commercial Service's user fee
schedule that became effective May 1, 2008 (for additional
information see https://www.export.gov/newsletter/march2008/initiatives.html).
---------------------------------------------------------------------------
Expenses for lodging, some meals, incidentals, and travel (except
for transportation to and from meetings) will be the responsibility of
each mission participant.
Conditions for Participation
An applicant must submit a completed and signed mission
application and supplemental application materials, including adequate
information on the company's products and/or services (or in the case
of a trade association or trade organization, information on the
products and/or services of the companies to be represented on the
trade mission), primary market objectives, and goals for participation.
If the Department of Commerce receives an incomplete application, the
Department may reject the application, request additional information,
or take the lack of information into account when evaluating the
applications.
Each applicant must also certify that the products and
services it seeks to export through the mission are either produced in
the United States, or, if not, marketed under the name of a U.S. firm
and have at least fifty-one percent U.S. content. In the case of a
trade association or trade organization, the applicant must certify
that, for each company to be represented by the trade association or
trade organization, the products and services the represented company
seeks to export are either produced in the United States, or, if not,
marketed under the name of a U.S. firm and have at least fifty-one
percent U.S. content.
Selection Criteria for Participation
Selection will be based on the following criteria:
Suitability of a company's (or, the case of a trade
association or trade organization, representing companies') products or
services to the mission's goals.
Company's (or, in the case of a trade association or trade
organization, represented companies') potential for business in India,
including likelihood of exports resulting from the trade mission.
Consistency of the applicant's goals and objectives with
the stated scope of the trade mission.
Referrals from political organizations and any documents containing
references to partisan political activities (including political
contributions) will be removed from an applicant's submission and not
considered during the selection process.
Timeframe for Recruitment and Applications
Mission recruitment will be conducted in an open and public manner,
including publication in the Federal Register (https://www.gpoaccess.gov/fr), posting on ITA's trade mission calendar--
www.trade.gov/trade-missions--and other Internet Web sites, press
releases to general and trade media, direct mail, broadcast fax,
notices by industry trade associations and other multiplier groups, and
publicity at industry meetings, symposia, conferences, and trade shows.
Recruitment for the mission will begin immediately and conclude no
later than December 22, 2011. The U.S. Department of Commerce will
review applications and make selection decisions on a rolling basis. We
will inform all applicants of selection decisions as soon as possible
after the applications are reviewed. Applications received after the
December 22 deadline will be considered only if space and scheduling
constraints permit.
Contacts
U.S. Commercial Service
Ms. September Secrist, Healthcare Team: International Trade Specialist,
U.S. Commercial Service, U.S. Department of Commerce, 2001 6th Avenue,
Suite 2610, Seattle, WA 98121, Phone: (206) 553-5615x229, Fax: (206)
553-7253.
U.S. Commercial Service in India
Ms. Ruma Chatterjee, U.S. Commercial Service Mumbai, Ph: 91-22-2265
2511, Fax: 91-22-22652850, Ruma.Chatterjee@trade.gov.
Mr. Sandeep Maini, U.S. Commercial Service New Delhi, Ph: 91-11-
23472222, Fax: 91-11-2331 5172, Sandeep.Maini@trade.gov.
Elnora Moye,
Trade Program Assistant.
[FR Doc. 2011-28590 Filed 11-9-11; 8:45 am]
BILLING CODE 3510-FP-P